GRAFAPEX 5000 mg/5g
treosulfan · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Medexus Pharma, Inc.
Treosulfan is an intravenous chemotherapy medication used to prepare patients for stem cell or bone marrow transplantation. It works by destroying cancer cells and suppressing the immune system to allow transplanted cells to take hold.
Key Facts
- Brand Name
- GRAFAPEX
- Generic Name
- treosulfan
- NDC Code (Product)
59137-365- Manufacturer
- Medexus Pharma, Inc.
- Strength
- 5000 mg/5g
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA214759
- Marketing Start
- 01/28/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is GRAFAPEX used for?
Treosulfan is an intravenous chemotherapy medication used to prepare patients for stem cell or bone marrow transplantation. It works by destroying cancer cells and suppressing the immune system to allow transplanted cells to take hold.
Is GRAFAPEX a controlled substance?
GRAFAPEX is not classified as a controlled substance by the DEA.
What is the generic name for GRAFAPEX?
The generic name for GRAFAPEX is treosulfan. There are no other listed brand versions of treosulfan.
What is the NDC code for GRAFAPEX 5000 mg/5g?
The NDC (National Drug Code) for GRAFAPEX 5000 mg/5g is 59137-365, listed by Medexus Pharma, Inc..
Other GRAFAPEX Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)